AVTR
Undervalued by 73.2% based on the discounted cash flow analysis.
Market cap | $8.19 Billion |
---|---|
Enterprise Value | $8.70 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $1.05 |
Beta | 1.09 |
Outstanding Shares | 681,100,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 11.44 |
---|---|
PEG | 168.54 |
Price to Sales | 6.65 |
Price to Book Ratio | 1.66 |
Enterprise Value to Revenue | 4.99 |
Enterprise Value to EBIT | 26.84 |
Enterprise Value to Net Income | 14 |
Total Debt to Enterprise | 0.1 |
Debt to Equity | 0.14 |
No data
No data
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries.